Know your HIV status? Text: Your Zip Code to KnowIt or 566948 to find HIV test centers near you www.HIVtest.org

Thursday, April 7, 2011

Condoms: you have so many choices!

A weird but informational video from the guys at The Guide To Getting It On about all the different types of condoms there are out there that can help make safer sex hot, quick and more pleasurable!

Friday, March 25, 2011

March's Safety Net Message

Send out this month's message to your friends, take the quick survey to tell us you did it, and enter our drawing for a chance to win a $25 gift card to CVS this month!

You're not alone! Hartford Gay & Lesbian Health Collective has many social and support groups so you can stay connected, happy & healthy. Go to http://www.hglhc.org/ for info. --Safety Net Team member

Once you've sent this by text, email, or posted it on your Twitter or Facebook account, take this survey to let us know how many people this reached and to enter our monthly drawing for a great prize.


Create your free online surveys with SurveyMonkey, the world's leading questionnaire tool.

Thursday, March 24, 2011

Are you lonesome tonight?

Hey guys! So my colleagues at HGLHC found a study that links HIV- risk behaviors with loneliness and a lack of social connectedness. Here are some excerpts:

“This article examines the Loneliness and Sexual Risk Model (LSRM) which postulates that loneliness is associated with sexual risk behavior and that this relationship is mediated by the influence of substance use and compulsive behavior. Therefore ,successfully addressing loneliness and its underlying causes likely to result in subsequent reductions in risk behaviors”.

“There is a growing body of research that focuses on sexual compulsivity and the use of the internet as a primary vehicle to act out sexually (Dew & Chaney, 2004). Because of the possible consequences of being exposed in public venues and the lack of alternative venues for socialization, the internet is an appealing method for some MSM to meet sexual partners (Brown, Maycock, & Burns, 2005). Internet use facilitates the process of identifying potential sex partners online and setting up sexual encounters among MSM, Model of Sexual Risk 69 which in turn have been associated with a rise of HIV infection in that population (Benotsch, Kalichman, & Cage, 2002). This is particularly true for those who feel a lack of social connectedness (Chaney & Dew, 2003).”

“An efficient and cost-effective way of incorporating social interaction and skill practice into therapy is to provide group interventions. Groups are a social microcosm that can provide individuals with the opportunity to practice social behaviors and interpersonal skills, as well as facilitate the generalization and application of the learned skills to real life in a safe environment.”

So, what do you guys think? We all get lonely, but there are some great alternatives so you can keep yourself surrounded with supportive people and make healthy choices for yourself. Have you checked out our social group for young gay and bisexual men, MPowerCT? Ever heard about our group for men called Living Soulfully, a group that supports the spiritual lives of gay/bi/questioning men?

You can even get out of your loneliness rut by texting or emailing or Facebooking the monthly Safety Net messages! Are you already on our Safety Net team? If not, email Jamie to get started (jamieb@hglhc.org).


The link to the article is here: http://www.informaworld.com/smpp/content~db=all~content=a773636800

Compulsivity, Substance Use, and Loneliness: The Loneliness and Sexual Risk Model (LSRM)
Authors: Hctor L. Torresa; Cheryl Gore-Feltonb

Wednesday, March 9, 2011

News in HIV Treatment Research

From the March issue of the CT HIV/AIDS Planning Consortium News and Notes:

An HIV positive American living in Berlin has been cured from HIV. Reportedly, he has no detectable HIV in his blood after a stem cell transplant he underwent in 2007 to treat leukemia. The transplant was from a donor who carried a gene mutation that has a natural resistance to the virus.

It was by sheer coincidence that the “Berlin Patient” (as he has come to be known) was cured from HIV. The medical team deliberately chose a compatible donor who has a naturally occurring gene mutation that is resistant to the virus that causes AIDS. This type of mutation (known as CCR5delta32) is only found in between 1-3 percent of white poulations of European descendants. The people that have these wonderful genes have a natural protection to HIV.

Unfortunately, this treatment will not be able to help most people infected with HIV. Stem cell transplants are too dangerous and extreme to be used routinely, as many people die using stem cell transplants. The case of the “Berlin Patient”, however, paves a path for constructing a permanent cure for HIV through genetically-engineered stem cells.

I've heard this issue come up a few times at HIV counseling and testing sessions with our clients. While this is promising, it's a LONG ways away from a cure. The best we can do for now is to protect ourselves from HIV by choosing safer sex to prevent HIV infections and prevent the spread of this disease, to avoid contact with blood, and to avoid sharing needles with anyone else.

Stay safe!

--Jamie

Tuesday, March 1, 2011

New study says: Half of men may have HPV infections

CHICAGO (Reuters) – Half of men in the general population may be infected with human papillomavirus or HPV, the human wart virus that causes cervical and other cancers, strengthening the case for vaccinating boys against HPV, U.S. researchers said on Monday.


Yikes. Read the full story here: http://news.yahoo.com/s/nm/20110301/hl_nm/us_cancer_vaccine

Smart Phone Apps are Now Helping People Take Their Meds

Pretty cool--- smart phone apps are helping people to remember to take their medications (including HIV meds).

The Importance of Medication Adherence to People Living with HIV/AIDS:


When you take a drug, it gets processed by your body and enters into your blood stream. The HIV drugs need to stay in your blood at certain levels to fight HIV. If the level falls too low, the drugs cannot work well.

When you take your pills on schedule, you keep the right level of the drug in your body. By not taking your medicines on schedule, you risk letting drug levels drop. This may allow HIV to make copies of itself and even make changes (mutations). These mutations can help the virus survive, even when you do take your HIV medication. This is called resistance.

When HIV becomes resistant to a drug you are taking, that drug will probably stop working. This may lead to an increase in your viral load and a decrease in your CD4 cell count. At that point, you will probably have to switch to another HIV drug.

Resistance to one drug can sometimes cause resistance to other drugs you have not taken. (This is called cross-resistance.) Resistance can affect your treatment choices in the future because fewer drugs will work well against your virus.

The best way to prevent resistance is to stick closely to your medication schedule. Some studies suggest that 95 percent adherence may be needed to get the most benefit from HIV treatment. That means missing very few doses.

[from the Well Project: http://www.thewellproject.org/en_US/Treatment_and_Trials/Things_to_Consider/Women_and_Adherence.jsp ]

Tuesday, February 22, 2011

What'd you get for Valentine's Day?


Hi Safety Net Team!

Please send out the monthly Safety Net message to your friends-- especially men who love men-- and then let us know how many messages you sent by clicking on the survey link after the jump (it's short and sweet, I promise!).

What did you get for Valentine's Day? Hopefully nothing, but get an HIV & STD test to be sure! Get ur HIV test for FREE at HGLHC. Mention the code "SafetyNet" when you make an appointment. 860-278-4163 Get ur HIV test for FREE at HGLHC. Mention the code "SafetyNet" when you make an appointment. 860-278-4163 Now thru 3/14/2011 info@hglhg.org
Once you've shared this message, please take the quick survey here: http://www.surveymonkey.com/s/77886C3

Thursday, December 30, 2010

Safety Net Message for December

Have a healthy 2011: schedule your HIV test today at the Hartford Gay & Lesbian Health Collective. Email info@hglhc.org. Happy New Year!

--from your friends on the Safety Net Team

Please share this with everyone-- ESPECIALLY all the men who love men who are in your life-- friends, family, lovers, hookups, & strangers! post it on Facebook, Twitter, Myspace (uhh if you still use it).... send it to cuties on ManHunt and Grindr....  wish everyone a safe and happy new year!

And once you share it, do yourself a favor and take this quick survey to let me know that you shared this important health reminder. You will be entered into a drawing to WIN a $10 GIFT CARD to TISANE. Winner will be notified by 1/20/2011. The survey is here: http://www.surveymonkey.com/s/ZW8V337


Stay safe, play safe, lovies. And enjoy ringing in the new year. Oh, and make SURE you have a designated driver-- I don't wanna be bailing any of you out, but more importantly, I want you to take care of yourself and others coz you're beautiful and worth it.

-Jamie
Safety Net Team Captain

Centers for Disease Control and Prevention

Sexually Transmitted Diseases Treatment Guidelines, 2010
Recommendations and Reports December 17, 2010 / Vol. 59 / No. RR-12

Men Who Have Sex with Men (MSM)
Subgroups of MSM are at high risk for HIV infection and other viral and bacterial STDs. The frequency of unsafe sexual practices and the reported rates of bacterial STDs and incident HIV infection declined substantially in MSM from the 1980s through the mid-1990s. However, since that time, increased rates of early syphilis (primary, secondary, or early latent), gonorrhea, and chlamydial infection and higher rates of unsafe sexual behaviors have been documented among MSM in the United States and virtually all industrialized countries (103,104). The effect of these behavioral changes on HIV transmission has not been ascertained, but preliminary data suggest that the incidence of HIV infection is increasing among MSM in some urban centers, particularly among MSM from racial and ethnic minority groups (105) and among those who use nonprescription drugs during sex, particularly methamphetamine and volatile nitrites (also known as “poppers”). These adverse trends likely reflect the 1) changing attitudes concerning HIV infection that have accompanied advances in HIV therapy, resulting in improved quality of life and survival for HIV-infected persons; 2) changing patterns of substance abuse; 3) demographic shifts in MSM populations; and 4) changes in sex partner networks resulting from new venues for partner acquisition (e.g., the internet). Increases in bacterial STDs are not necessarily accompanied by increases in HIV incidence; for example, oral sex may permit efficient spread of bacterial STDs but not HIV, as does serosorting (preferential selection of sex partners of the same serostatus) among HIV-infected MSM (106,107).

Clinicians should assess the STD-related risks for all male patients, including a routine inquiry about the sex of sex partners.

MSM, including those with HIV infection, should routinely undergo nonjudgmental STD/HIV risk assessment and client-centered prevention counseling to reduce the likelihood of acquiring or transmitting HIV or other STDs. Clinicians should be familiar with the local community resources available to assist MSM at high risk in facilitating behavioral change and to enable the conduct of partner notification activities. Clinicians also should routinely ask sexually active MSM about symptoms consistent with common STDs, including urethral discharge, dysuria, genital and perianal ulcers, regional lymphadenopathy, skin rash, and anorectal symptoms consistent with proctitis, including discharge and pain on defecation or during anal intercourse. Clinicians should perform appropriate diagnostic testing on all symptomatic patients.

Routine laboratory screening for common STDs is indicated for all sexually active MSM. The following screening tests should be performed at least annually for sexually active MSM:

• HIV serology, if HIV negative or not tested within the previous year;
• syphilis serology, with a confirmatory testing to establish whether persons with reactive serologies have incident untreated syphilis, have partially treated syphilis, or are manifesting a slow serologic response to appropriate prior therapy;
• a test for urethral infection with N. gonorrhoeae and C. trachomatis in men who have had insertive intercourse† during the preceding year; testing of the urine using nucleic acid amplification testing (NAAT) is the preferred approach;
• a test for rectal infection§ with N. gonorrhoeae and C. trachomatis in men who have had receptive anal intercourse* during the preceding year (NAAT of a rectal swab is the preferred approach); and
• a test for pharyngeal infection§ with N. gonorrhoeae in men who have had receptive oral intercourse† during the preceding year (NAAT is the preferred approach). Testing for C. trachomatis pharyngeal infection is not recommended.

Evaluation for HSV-2 infection with type-specific serologic tests also can be considered if infection status is unknown; knowledge of HSV-2 serostatus might be helpful in identifying persons with previously undiagnosed genital tract infection.

Because of the increased incidence of anal cancer in HIV-infected MSM, screening for anal cytologic abnormalities can be considered; however, evidence is limited concerning the natural history of anal intraepithelial neoplasias, the reliability of screening methods, the safety and response to treatments, and the programmatic support needed for such a screening activity.

More frequent STD screening (i.e., at 3–6-month intervals) is indicated for MSM who have multiple or anonymous partners. In addition, MSM who have sex in conjunction with illicit drug use (particularly methamphetamine use) or whose sex partners participate in these activities should be screened more frequently. All MSM should be tested for HBsAg to detect HBV infection.

Prompt identification of chronic infection with HBV is essential to ensure necessary care and services to prevent transmission to others (108). HBsAg testing should be made available in STD treatment settings. In addition, screening among past or current drug users should include HCV and HBV testing.

Vaccination against hepatitis A and B is recommended for all MSM in whom previous infection or vaccination cannot be documented (2,3). Preimmunization serologic testing might be considered to reduce the cost of vaccinating MSM who are already immune to these infections, but this testing should not delay vaccination. Vaccinating persons who are immune to HAV or HBV infection because of previous infection or vaccination does not increase the risk for vaccine-related adverse events (see Hepatitis B, Prevaccination Antibody Screening). Sexual transmission of hepatitis C virus infection can occur, especially among HIV-infected MSM. Serologic screening for hepatitis C infection is recommended at initial evaluation of newly diagnosed HIV-infected persons. HIV-infected MSM can also acquire HCV after initial screening; therefore, men with new and unexplained increases in alanine aminotransferase (ALT) should be tested for acute HCV infection. To detect acute HCV infection among HIV-infected MSM with high-risk sexual behaviors or concomitant ulcerative STDs, routine HCV testing of HIV-infected MSM should be considered.

† Regardless of history of condom use during exposure.
§ Commercially available NAATS are not FDA cleared for these indications, but they can be used by laboratories that have met all regulatory requirements for an off-label procedure.